This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
$0.04467
Share price
0.00%
Change (1 day)
-99.21%
Change (1 year)
Categories
ViewRay (VRAY) - P/B ratio
P/B ratio as of April 2025 : 0.0830
According to ViewRay's latest financial reports the company has a price-to-book ratio of 0.0448604.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
ViewRay - P/B ratio (from 2015 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 9.88 | 71.82% |
| 2021-12-31 | 5.75 | 32.08% |
| 2020-12-31 | 4.35 | 51.55% |
| 2019-12-31 | 2.87 | -17.78% |
| 2018-12-31 | 3.49 | -98.89% |
| 2017-12-31 | 314 | -10184.99% |
| 2016-12-31 | -3.12 | -89.68% |
| 2015-12-31 | -30.2 | |
| 2014-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 0.0830 | 0.00% | 🇺🇸 USA |
 | 0.6264 | 654.94% | 🇺🇸 USA |
 | 1.70 | 1,951.34% | 🇮🇱 Israel |